Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients
Clinical trial NCT05014646 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05014646
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-07
- Primary completion
- 2027-01-16
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.